<code id='8FB1400506'></code><style id='8FB1400506'></style>
    • <acronym id='8FB1400506'></acronym>
      <center id='8FB1400506'><center id='8FB1400506'><tfoot id='8FB1400506'></tfoot></center><abbr id='8FB1400506'><dir id='8FB1400506'><tfoot id='8FB1400506'></tfoot><noframes id='8FB1400506'>

    • <optgroup id='8FB1400506'><strike id='8FB1400506'><sup id='8FB1400506'></sup></strike><code id='8FB1400506'></code></optgroup>
        1. <b id='8FB1400506'><label id='8FB1400506'><select id='8FB1400506'><dt id='8FB1400506'><span id='8FB1400506'></span></dt></select></label></b><u id='8FB1400506'></u>
          <i id='8FB1400506'><strike id='8FB1400506'><tt id='8FB1400506'><pre id='8FB1400506'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:74
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul
          Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

          IsraelisblockahighwayastheyprotestagainstplansbyPrimeMinisterBenjaminNetanyahu'sgovernmenttooverhaul

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Addiction experts warn against a second 'war on drugs'

          STAT'sLevFacher(left)spokewiththreeaddictionexperts—(fromleft)BraunzCourtney,KeithHumphreys,andAyesh